Sun Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹10,931 Crore, up from ₹9,447 Crore year on year depicting a growth of 16%. Consolidated Net Profit of ₹1,984 Crore, up 187% from -(₹2,227) Crore in the same quarter of the previous year. The Earnings per Share is ₹8.3, up 187% from -(₹9.49) in the same quarter of the previous year.
Sun Pharmaceuticals Ltd Q4FY23 results out, revenue grows by 16%
Related Post
- SMC Global Securities Ltd Q2FY25; 15% rise in Profits
SMC Global Securities Ltd (SMC) is a well-diversified financial service company in India & Abroad,…
-
Natco Pharma Ltd Q2FY25; 83% rise in Profits
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged…
-
Muthoot Finance Ltd Q2FY25; 26% rise in Profits
Muthoot Finance is NBFC engaged in the business of providing gold loans. The company predominately…